Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.660
-0.010 (-0.60%)
At close: Apr 24, 2026, 4:00 PM EDT
1.640
-0.020 (-1.20%)
After-hours: Apr 24, 2026, 7:58 PM EDT
Ocugen Market Cap
Ocugen has a market cap or net worth of $561.94 million as of April 24, 2026. Its market cap has increased by 177.48% in one year.
Market Cap
561.94M
Enterprise Value
576.51M
1-Year Change
177.48%
Ranking
Category
Stock Price
$1.66
Market Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $561.94M, an increase of 1,615.87%. That is a compound annual growth rate of 54.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 561.94M | 33.28% |
| Dec 31, 2025 | 421.63M | 79.79% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eikon Therapeutics | 579.28M |
| Shattuck Labs | 578.20M |
| Prothena Corporation | 577.63M |
| Sutro Biopharma | 577.04M |
| CorMedix | 574.88M |
| Rigel Pharmaceuticals | 567.71M |
| Lyell Immunopharma | 550.55M |
| Verastem | 547.26M |